Xiaoli Li
- Oncology
- Cardiology and Cardiovascular Medicine
- Molecular Biology
- Surgery
- Pulmonary and Respiratory Medicine
- Co-authors
- Liping DongLinlin LiuLining WangZilong LiLi YaoYi JiangZhenghui WangYun Liu
- Topics
- Antiplatelet Therapy and Cardiovascular Diseases (4 papers)Inflammatory mediators and NSAID effects (4 papers)Lung Cancer Research Studies (3 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaScientific Reports
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Xiaoli Li
39 papers receiving 402 citations
Peers
Comparison fields: 5 of 83
- Oncology 84
- Cardiology and Cardiovascular Medicine 74
- Molecular Biology 73
- Surgery 67
- Pulmonary and Respiratory Medicine 66
Countries citing papers authored by Xiaoli Li
This map shows the geographic impact of Xiaoli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Li more than expected).
Fields of papers citing papers by Xiaoli Li
This network shows the impact of papers produced by Xiaoli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Li. The network helps show where Xiaoli Li may publish in the future.
Co-authorship network of co-authors of Xiaoli Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Li. A scholar is included among the top collaborators of Xiaoli Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Li. Xiaoli Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 4 | |
| 8 | 13 | |
| 9 | 7 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 16 | |
| 13 | 23 | |
| 14 | 36 | |
| 15 | 17 | |
| 16 | A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation. | 15 |
| 17 | 58 | |
| 18 | 14 | |
| 19 | 32 | |
| 20 | 20 |
About Xiaoli Li
Xiaoli Li is a scholar working on Internal Medicine, Oncology and Pharmacology, having authored 41 papers that have together received 411 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Nephrology (53 citations), Internal Medicine (19 citations) and Hematology (37 citations). Xiaoli Li has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Liping Dong, Linlin Liu, Lining Wang, Zilong Li, Li Yao, Yi Jiang, Zhenghui Wang, Yun Liu, Miao Liu and Chunyan Yang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.